Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases – a claims data analysis

L. Schwarzkopf (Neuherberg, Germany), S. Witt (Neuherberg, Germany), J. Waelscher (Heidelberg, Germany), M. Polke (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany)

Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Session: Management of idiopathic interstitial pneumonias: established and new treatments
Session type: Thematic Poster
Number: 4793
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Schwarzkopf (Neuherberg, Germany), S. Witt (Neuherberg, Germany), J. Waelscher (Heidelberg, Germany), M. Polke (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany). Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases – a claims data analysis. 4793

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Associations between comorbidities and survival in patients with interstitial lung diseases
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases)
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

The prevalence of poor sleep quality and its associated factors in patients with interstitial lung disease: a cross-sectional analysis
Source: ERJ Open Res, 5 (3) 00062-2019; 10.1183/23120541.00062-2019
Year: 2019



The associations of interstitial lung abnormalities with cancer diagnoses and mortality
Source: Eur Respir J, 56 (6) 1902154; 10.1183/13993003.02154-2019
Year: 2020



Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease: a retrospective cohort study
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019


Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Clinical characteristics, mortality rates and causes of death in non-exacerbating COPD patients. A longitudinal cohort analysis of UK primary care data.
Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies
Year: 2021



Incidence and burden of major comorbidities among individuals with COPD: a comprehensive analysis using data from primary care
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009

Assessing the multivariate structure and influence of comorbidity in COPD
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005


Factors affecting the duration from diagnosis to treatment in patients with lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 668s
Year: 2007

Correlation between life quality parameters and anthropometric data in the patients with chronic obstructive lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 515s
Year: 2005

The analysis of prognostic factors in patients with interstitial lung diseases
Source: International Congress 2015 – New insights into IIPs
Year: 2015


The association between lung function and exacerbation frequency in patients with COPD, results from a systemic review
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009

Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC)
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019


Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
Source: International Congress 2016 – IPF clinical
Year: 2016

Comparison of comorbidities between two different subgroups in combined assessment of COPD
Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease
Year: 2016

Discharge support and readmission of older patients with lung cancer
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007


Information on coexisting diseases in patient files in newly referred COPD patients in the KOLibri study
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007


Association between chronic comorbidity and exacerbation rate in primary care COPD patients. Preliminary analysis of real-life general practice data (PROSPECT1)
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016


IPF cluster analysis highlights diagnostic delay and cardiovascular comorbidities association with outcome
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021